CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis

Previously, we described an APC-adenovirus (APC-Ad) FasL cell gene therapy method which could be used to deplete autoreactive T cells in vivo. FasL was toxic, however, and controlled regulation of FasL was not achieved. Here we describe an improved approach to delivering TNF-related apoptosis-induci...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Clin Invest
Päätekijät:	Liu, Zhongyu, Xu, Xin, Hsu, Hui-Chen, Tousson, Albert, Yang, Ping-Ar, Wu, Qi, Liu, Cunren, Yu, Shaohua, Zhang, Huang-Ge, Mountz, John D.
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Clinical Investigation 2003
Aiheet:	Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC228459/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14597760/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI19209
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!